VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $38,323,000 | +46.0% | 1,648,992 | 0.0% | 14.52% | +31.2% |
Q1 2018 | $26,252,000 | +747.9% | 1,648,992 | +1006.8% | 11.07% | +735.9% |
Q4 2017 | $3,096,000 | -92.9% | 148,992 | -95.1% | 1.32% | -91.3% |
Q3 2017 | $43,762,000 | -17.5% | 3,053,843 | 0.0% | 15.29% | -6.6% |
Q2 2017 | $53,030,000 | +104.3% | 3,053,843 | +29.7% | 16.38% | +90.1% |
Q1 2017 | $25,963,000 | -8.8% | 2,353,843 | +20.0% | 8.61% | -5.4% |
Q4 2016 | $28,471,000 | -19.8% | 1,960,843 | +35.5% | 9.10% | -30.7% |
Q3 2016 | $35,520,000 | +21.9% | 1,446,843 | 0.0% | 13.14% | +18.2% |
Q2 2016 | $29,139,000 | +13.3% | 1,446,843 | +48.1% | 11.12% | +33.2% |
Q1 2016 | $25,725,000 | – | 976,843 | – | 8.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |